be_ixf;ym_202201 d_20; ct_50

Ruxolitinib, a New Topical Cream Could Effectively Reverse Vitiligo, According to New Study

If you’re not sure exactly what vitiligo is, you’ve surely seen someone who has it — the autoimmune condition is relatively common, for starters, and there’s also been a recent concerted effort to raise awareness about it in the media. Thanks to public figures like Winnie Harlow, who just made history as the first model with vitiligo to get cast in the iconic Sports Illustrated Swimsuit Issue, and admirable beauty campaigns from brands like Fenty and CoverGirl, vitiligo is finally becoming more widely understood and accepted. And because of a new study, a better treatment option for those with vitiligo could be on the way.

To get technical for a minute, Ruxolitinib is part of a class of medications called Janus Kinase (JAK) inhibitors, explains Jeremy Fenton, a dermatologist at Schweiger Dermatology Group in New York City. “These drugs disrupt the inflammatory pathway by blocking the signaling of molecules, [which] leads to an anti-inflammatory effect,” Fenton says.

Read full article here

Source: Allure – Ruxolitinib, a New Topical Cream Could Effectively Reverse Vitiligo, According to New Study By, Rebecca Dancer

About Schweiger Dermatology Group

Schweiger Dermatology Group was founded to help make excellent dermatology care accessible throughout the Northeast. In 2010, Dr. Eric Schweiger started the practice with a single location in Midtown Manhattan. When he saw the need for high-quality dermatology care that did not require weeks or months of waiting to see a qualified provider, his vision of a multi-location practice was born.

Back to Top

Receive skincare tips, news and special offers!

Field marked with asterisk (*) is mandatory.